Press Release June 25, 2021Sanofi: Libtayo® (cemiplimab) approved by the European Commission as the first immunotherapy indicated for patients with advanced basal cell carcinoma 0 0 Share
Press Release June 25, 2021Libtayo® (cemiplimab) Approved by the European Commission for First-Line Treatment of Patients with Advanced Non-small Cell Lung Cancer with ≥50% PD-L1 Expression 0 0 Share
Press Release June 25, 2021Sanofi: Libtayo® (cemiplimab) approved by the European Commission for first-line treatment of patients with advanced non-small cell lung cancer with ≥50% PD-L1 expression 0 0 Share
Press Release June 24, 2021Findit Features Members Global WholeHealth Partners, ClassWorx and OTC Tip Reporter Who Utilize Findit Marketing Campaigns To Improve Online Exposure 0 0 Share
Press Release June 24, 2021Cybin Announces Former FDA Psychiatry Division Director Dr. Thomas Laughren has Joined Clinical Advisory Board 0 0 Share
Press Release June 24, 2021Nokia launches next-generation AirScale 5G portfolio powered by ReefShark technology 0 0 Share
Press Release June 24, 2021LYNPARZA® (olaparib) Approved in China for the Treatment of Certain Patients with BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer 0 0 Share
Press Release June 24, 2021In the Race to Combat Climate Change, C.H. Robinson Sees 654% Increase in Renewables Business While the Booming Clean Energy Sector Faces Five Key Logistics Challenges 0 0 Share
